Synthesis of novel flavanone derivatives and their anti Staphylococcus aureus evaluation

Qing-hui Xu , Ji-zhen Li , Jiang-hua He , Xin Zhao , Qi-sheng Huo

Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (4) : 695 -698.

PDF
Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (4) : 695 -698. DOI: 10.1007/s40242-013-2519-7
Article

Synthesis of novel flavanone derivatives and their anti Staphylococcus aureus evaluation

Author information +
History +
PDF

Abstract

The authors synthesized two novel flavanones bearing iso-pentenyl side chain and evaluated their anti Staphylococcus aureus(S. aureus) activity. The target compounds 7a[2-5′-(1″,2″-dimethylallyl)-2′-methoxy-4′,5,7-tetrahydroxyflavanone] and 7b[2-5′-(1″,2″-dimethylallyl)-3′-methoxy-4′,5,7-tetrahydroxyflavanone]_were synthesized respectively through total four steps starting from 2,4,6-trihydroxy acetophenone(3) and the corresponding iso-pentenyl substituted benzaldehyde(1), in which the 1,2-dimethyl-2-propenyl group had been introduced previously via abnormal Claisen rearrangement. The bioactivities of the two flavanones against S. aureus strains ATCC 25923, 29213, and MRSA 252 were evaluated, showing the same minimum inhibitory concentration(MIC) value of 16 μg/mL.

Keywords

Flavanone / Abnormal Claisen rearrangement / Antimicrobial / iso-Pentenyl side chain

Cite this article

Download citation ▾
Qing-hui Xu, Ji-zhen Li, Jiang-hua He, Xin Zhao, Qi-sheng Huo. Synthesis of novel flavanone derivatives and their anti Staphylococcus aureus evaluation. Chemical Research in Chinese Universities, 2013, 29(4): 695-698 DOI:10.1007/s40242-013-2519-7

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Levy S B, Marshall B. Nat. Med., 2004, 10: 122.

[2]

Barrett J F. Expert Opin. Ther. Targets, 2005, 9: 253.

[3]

Bryskier A. Expert Rev. Anti. Infect Ther., 2005, 3: 505.

[4]

Walsh C T. Nat. Rev. Microbiol., 2003, 1: 65.

[5]

Ding Y J, Nie Y, Yu Y. Chem. Res. Chinese Universities, 2011, 27(4): 651.

[6]

Mitchell M O. Anti. Infect. Agents Med. Chem., 2007, 6: 243.

[7]

Arias C A, Murray B E N. Eng. J. Med., 2009, 360: 439.

[8]

Liu X L. Eur. J. Med. Chem., 2008, 43: 1681.

[9]

Straus S K, Hancock R E W. Biochim. Biophys. Acta, 2006, 1758: 1215.

[10]

Tanaka H, Sato M, Fujiwara S, Hirata M. Lett. Appl. Microbiol., 2002, 35: 494.

[11]

Raghukumar R, Vali L, Watson D, Fearnley J, Seidel V. Phytother Res., 2010, 24: 1181.

[12]

Halsteen B. Biochem. Pharmacol., 1983, 32: 1141.

[13]

Silberberg M, Gil Izquierdo A, Combaret L, Remesy C, Scalbert A, Morand C. Biomed. Pharmacother., 2006, 60: 529.

[14]

Shi L, Feng X E, Fang L H, Du G H, Li Q S. Chem. Res. Chinese Universities, 2011, 27(2): 237.

[15]

Khan M S Y, Hasan S M. Indian J. Chem., 2003, 42: 1970.

[16]

Smejkal K, Chudik S. J. Nat. Prod., 2008, 71: 706.

[17]

Inui S, Hosoya T, Shimamura Y, Masuda S, Ogawa T, Kobayashi H, Kumazawa S. J. Agric. Food. Chem., 2012, 60: 11765.

[18]

Smejkal K, Svacinova J. J. Nat. Prod., 2010, 73: 568.

[19]

Younghwa N, Jeong-Heon C. Chem. Pharm. Bull., 2009, 57: 607.

[20]

Kromann H, Larsen M. Eur. J. Med. Chem., 2004, 39: 993.

[21]

Minassi K, Giana A, Ech-Chahad A, Appendino G. Org. Lett., 2008, 10: 2267.

[22]

Li J Z, Mi Y H, He J H, Deng X M. Synlett., 2010, 15: 2289.

[23]

He J H, Li J Z, Liu Z Q. Med. Chem. Res., 2013, 22: 2847.

[24]

Venkateswara B, Ramanjaneyulu K, Bhaskara T, Rambabu T. J. Chem. Pharm. Res., 2011, 3: 49.

[25]

Roelens F, Heldring N. J. Med. Chem., 2006, 49: 7357.

[26]

Chin N, Neu H C. Diagn. Microbiol. Infect. Dis., 1992, 15: 549.

AI Summary AI Mindmap
PDF

117

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/